آخر المشاركات
         :: أفضل نظام إدارة الأداء الذكي (آخر رد :جنى ميرو)      :: افضل شركة خزانات مياة فى مصر (آخر رد :جنى ميرو)      :: أفضل دكتور جراحة أورام عند السفر لمصر (آخر رد :جنى ميرو)      :: أفضل دكتور جراحة أورام عند السفر لمصر (آخر رد :جنى ميرو)      :: أفضل دكتور جراحة أورام في الهرم (آخر رد :جنى ميرو)      :: best binary software (آخر رد :جنى ميرو)      :: افضل دكتور جراحة أورام في مصر (آخر رد :جنى ميرو)      :: خبراء الشعر المستعار: تمتعي بجمال شعرك الطبيعي دون أي مجهود (آخر رد :جنى ميرو)      :: عالم الجوال لاكسسوارات الجوال داخل المملكة العربية السعودية (آخر رد :جنى ميرو)      :: عالم الجوال لاكسسوارات الجوال داخل المملكة العربية السعودية (آخر رد :جنى ميرو)     


العودة   كل الطب أكبر منتديات طبية عربية 10 أعوام من العطاءAllteb 10 Years of Donation > الأطباء بعد التخرج Postgraduate doctors > ° التـخـصـصـات والـمـراجــع الطـبـية ° > Psychiatry

إضافة رد
 
أدوات الموضوع انواع عرض الموضوع
قديم 03-14-2009, 10:47 AM   #1
elekhtyar
Banned
 
تاريخ التسجيل: Jan 2009
العمر: 38
المشاركات: 3,507
افتراضي Negative Symptom and Cognitive Deficit Treatment Response in Schizophrenia

نقرتين لعرض الصورة في صفحة مستقلة


Negative Symptom and Cognitive Deficit Treatment Response in Schizophrenia
By Richard S. E. Keefe, J. P. McEvoy


Publisher: American Psychiatric Publishing, Inc.
Number Of Pages: 216
Publication Date: 2001-01
ISBN-10 / ASIN: 0880487852
ISBN-13 / EAN: 9780880487856


Product Description:

For the first time in a single volume, distinguished experts address the complex issues—issues rarely confronted in empirical studies of patients with schizophrenia—and controversial research surrounding the assessment of negative symptoms and cognitive deficits in patients with schizophrenia.

Despite recent advances in our understanding of schizophrenia, still notably absent is consensus in assessing negative symptom treatment response. What is the most effective assessment method—given the varying methodologies and contradictory results to date? What constitutes an adequate response? Which medication—none is specifically indicated and licensed for negative symptom treatment—yields the best results? What are the indications for use of this medication? Which instrument best measures negative symptom treatment response (eight rating scales are analyzed here)? Reaching consensus among clinicians and researchers alike is even more difficult because assessment is often thwarted by extrapyramidal side effects of medications, similarities to depressive symptoms, and secondary effects of psychotic experiences.

In addition to clarifying these pressing issues, Negative Symptom and Cognitive Deficit Treatment Response in Schizophrenia also discusses

The importance of measuring the experience of emotion versus the more traditional objectively measured symptoms in patients with schizophrenia, and how deficits in emotional experience may resist treatment—even in treatment-responsive patients.

The family as an often overlooked source of information about negative symptom improvement or worsening, and the impact of negative symptoms on patients' relatives.

How treatment affects social functioning and subjective experience of "quality of life," and the importance of neurocognitive dysfunction in the social deficits of schizophrenia, which often persist despite significant amelioration of other symptoms.

Specific guidelines for assessing neurocognitive treatment response. Cognitive enhancement is a major factor in improving the quality of patients' lives.

The latest research on the neurobiology of negative symptoms, including the role of various neurotransmitter systems and brain regions in mediating negative symptom pathology. Also discussed is single vs. multiple pathophysiological processes and single treatment modality vs. distinct treatments for different aspects of negative symptoms.

How to distinguish "pure" negative symptoms from deficit symptoms (i.e., those that persist for at least 1 year and are not secondary to factors such as depression, medication side effects, anxiety, delusions, and hallucinations), and which treatment is indicated for each.

Highlighted by patient vignettes, this in-depth guide will be welcomed by all clinicians who treat patients with schizophrenia and want to know and document whether their interventions ameliorate negative symptoms and cognitive dysfunction, and by all researchers who study schizophrenia, particularly those interested in clinical issues and treatment studies.



http://ifile.it/f9qbwpi/0880487852.rar

http://rapidshare.com/files/197904160/NSCDTRS.pdf
elekhtyar غير متواجد حالياً   رد مع اقتباس
إضافة رد

أدوات الموضوع
انواع عرض الموضوع

تعليمات المشاركة
لا تستطيع إضافة مواضيع جديدة
لا تستطيع الرد على المواضيع
لا تستطيع إرفاق ملفات
لا تستطيع تعديل مشاركاتك

BB code is متاحة
كود [IMG] متاحة
كود HTML معطلة



الساعة الآن 09:12 PM.


Powered by vBulletin Version 3.8.12 by vBS
Copyright ©2000 - 2023, Jelsoft Enterprises Ltd
Translation by Support-ar